SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Metagenics, Inc., a nutrigenomics and lifestyle medicine company dedicated to helping people live happier, healthier lives by realizing their genetic potential, today announced the relocation of its corporate and Americas region headquarters from San Clemente, Calif. to Aliso Viejo, Calif. The modern, efficiently designed, and LEED-certified facility not only supports Metagenics healthy lifestyle vision and mission, but also provides future space to accommodate the companys growth trend and goals. Metagenics will be relocating to its new headquarters beginning August 20. This move represents the right choice for us at a time when were making plans for the next phase of growth, said Fred Howard, chief executive officer of Metagenics. The new facility accommodates our growing employee base, enabling us to better serve the needs of our customers. Additionally, it provides an ideal environment that represents the healthy balance we strive for in our professional and personal lives. The facility, located at 25 Enterprise Parkway, is staged to accommodate the companys current office space with room for future growth. The building is certified for Leadership in Energy and Environmental Design (LEED) for more efficient use of resources, which often also provides a healthier work environment. We saw … Continue reading →

WEDNESDAY, Aug. 15 (HealthDay News) -- Dogs may soon become man's best friend on a level that goes far beyond companionship and loyalty. Researchers report that the canine genome, similar in many ways to the human one, is starting to shed light on a wide range of human diseases. What makes dogs particularly interesting to scientists is their breed structure -- a type of artificial selection -- which creates distinct and diverse lines of animals that range from the muscular German shepherd to the nervous Chihuahua, from the hard-working collie to the perpetually pampered poodle. According to a review article published Aug. 16 in the New England Journal of Medicine, the fact that most purebred dogs have descended from small, closely related parentage with large litters means recessive diseases are common among them. To those interested in genetics, that's exciting. It makes less common recessive diseases (which can't be seen or expressed unless the responsible gene is carried by both parents) more prevalent in these animals. And that opens the window to understanding the genetic underpinnings of a wide range of conditions that humans and dogs share. "The dog genome is very similar to humans," said review author Elaine Ostrander, … Continue reading →

A novel nanotechnology drug delivery system under development to infiltrate breast cancer tumors could pave the way for treating other diseases. Penn State College of Medicine received a $1 million grant from a state research fund set up with money from its tobacco settlement to assess the drug treatments commercialization potential. The principal investigator for the nanotechnology delivery system is Mark Kester, a professor of pharmacology and director of the Penn State Center for NanoMedicine and Materials. He has been working for the past five to six years with Jim Adair of Penn States department of material sciences and engineering, and Keystone Nano, a nanotechnology company spun out of Penn State University led by Jeff Davidson, the founder of the Biotechnology Institute and Pennsylvania Bio industry association. The next generation of cancer-fighting drugs specifically target cancer proteins rather than attack cancer and noncancer cells indiscriminately. Although companies have recognized the ability of small interfering RNA as a small molecule that can be directed to interfere with the production of cancer cells, the toxicity of siRNA has proved a challenge in its use. Biotechnology companies and institutions have been studying ways to use different nanotechnology particles to house the toxic molecule. … Continue reading →